DVSAnalytics, Inc.
The Contact Center Solution Providers are Teaming Up to Deliver Enhanced Capabilities and Value-Added Services
SAN ANTONIO, TX / ACCESSWIRE / March 20, 2024 / Dura Software portfolio companies DVSAnalytics and Infinity CCS have initiated a new partnership that promises to expand the capabilities of contact center software solutions worldwide. This collaboration aligns two contact center solution manufacturers to offer a broadened suite of Workforce Engagement Management (WEM) tools to their respective customer bases.
Infinity is a UK-based provider of interaction management software that brings a unique offering of contact center agent guidance solutions, encompassed within its newly rebranded product suite Maestro. The platform uses easy-to-script workflows and a comprehensive knowledge base to direct agents to the right response for every situation from a browser-based desktop application. Additional functionality includes AI-powered agent training tools and a host of APIs that make the Maestro platform technology-agnostic, creating seamless integrations to company directories and other mission-critical systems.
DVSAnalytics specializes in WEM applications for contact centers including call recording and screen recording, quality management, and speech analytics, as well as workforce management software, under its Encore brand. The union creates an affordable WEM toolset that better enables contact centers to train and prepare new agents. The partnership entails a reseller agreement between the two companies, enabling them to extend their reach and serve the needs of a larger partner network and client spectrum.
"We are entering a new era for contact center operations," says Chris Williams, CEO of both Infinity and DVSAnalytics. "This partnership marks a huge milestone for us, and we're looking forward to creating a powerhouse of combined contact center solution offerings that drive efficiency and excellence in customer interactions. This is an exciting time for both companies; with Infinity recently undergoing a rebranding and DVSAnalytics' continued growth in the WEM market, we believe that this partnership will allow us to deliver even more value to our customers."
For further information regarding this new partnership, please visit the Infinity and DVSAnalytics websites.
About Infinity
Infinity's technology and services unlock your ability to win customers, retain them, and maximize their satisfaction by empowering you to deliver exceptional customer experiences across multiple channels with ultimate efficiency. Our solutions have been built from the ground up for contact centers and are based around our proprietary technology - Infinity Maestro - and support services delivered by customer management experts. Infinity has over 20 years of experience working with contact centers, and Infinity Maestro is deployed in 13 countries around the world.
About DVSAnalytics
DVSAnalytics Inc. (DVS) workforce engagement management solutions (WEM) are designed to improve the customer experience and maximize employee engagement and productivity by offering analytics-enabled insights into customer interactions and contact center operations. DVS Encore® solutions include voice and desktop recording, analytics, quality and performance management, workforce management, reporting, and a powerful set of employee engagement capabilities.
About Dura Software
Dura Software acquires, owns, and operates a portfolio of growing niche software businesses that provide mission-critical solutions to end customers. Unlike other investors, Dura seeks to hold onto and operate its companies without any term limits. Dura is backed by founders and investors with deep experience in investing and operating companies across multiple industry verticals in various geographies.
Contact Information
Chris Williams
CEO
cwilliams@dvsanalytics.com
SOURCE: DVSAnalytics
To view this piece of content from stats.nwe.io, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
eComplete Partners with Sourceful to build AI-Native Creative Operations Across Portfolio18.11.2025 15:00:00 CET | Press release
MANCHESTER, UK / ACCESS Newswire / November 18, 2025 / eComplete, the private equity firm behind Current Body's £300 million London Stock Exchange listing, has announced a strategic partnership with Sourceful, the Manchester-based technology company whose Riverflow 1 model ranks as the world's leading AI image editing model. The partnership brings Sourceful's AI-native creative platform to eComplete's portfolio of direct-to-consumer brands, enabling them to generate brand-accurate, production-ready creative assets at scale across e-commerce, social, marketplace and retail. This makes eComplete the first major private equity investor to adopt AI-native creative infrastructure as a core operational advantage. Why this matters Every consumer brand today faces the same constraint: producing thousands of creative assets, product images, ads, videos, packaging, that feel authentically on-brand across every channel and market. This challenge has intensified dramatically over the past three ye
IXOPAY Appoints George Hansen as Chief Revenue Officer to Accelerate Global Growth in Tokenization, Orchestration, and Compliance18.11.2025 06:00:00 CET | Press release
Seasoned payments executive joins IXOPAY to lead global revenue strategy amid rapid growth and the rise of agentic commerce. LEHI, UTAH / ACCESS Newswire / November 18, 2025 / IXOPAY, a global leader in enterprise-grade payment orchestration, today announced the appointment of George Hansen as Chief Revenue Officer (CRO). A veteran of the payments and fintech industries, Hansen brings more than two decades of leadership experience driving growth, transformation, and customer-centric innovation at a global scale. In his new role, Hansen will drive IXOPAY's global revenue strategy, leading sales and partnerships and aligning with marketing and customer success to support enterprise merchants and partners worldwide. His appointment reinforces IXOPAY's commitment to giving merchants full control of their payment strategy through a vendor-neutral architecture designed for scale, flexibility, and intelligence. Hansen has held senior leadership positions at companies including American Expres
General Holdings Limited and NewOak Capital Form Strategic Joint Venture to Launch CMXG, an $800M Commodities Investment Platform18.11.2025 06:00:00 CET | Press release
DUBAI, AE / ACCESS Newswire / November 18, 2025 / General Holdings Limited (GH), a Dubai International Financial Centre-based multi-strategy private investment holding company, and NewOak Capital LLC, a New York collateralized private debt asset management and structured financing and capital markets firm, today announced the formation of Common Commodities CMXG (CMXG), a vertically integrated tech-enabled commodities investment platform designed to deliver risk-controlled, scalable institutional commodity-linked real yield and growth equity to qualified global investors. The partnership combines General Holdings' strategic capital and governance expertise with NewOak Capital's structured asset-based supply-chain financing capabilities and distribution platform. This sets the foundation for "a globally scalable, integrated and transparent institutional trade finance platform facilitating sustainable and inclusive cross-regional growth." Strategic Capital Deployment and Fund Launch CMXG
OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper
Camino Completes C$5.6 Million Investment with Strategic Investors17.11.2025 12:00:00 CET | Press release
VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of its -brokered private placement (the "Financing") of common shares in the capital of the Company (the "Shares") previously announced in its news release dated November 12, 2025. Under the Financing, the Company issued an aggregate of 15,554,666 Shares at an issue price of $0.36 per Share, for aggregate gross proceeds of C$5,599,680. Participants in the Financing included two new key shareholders, Elemental Royalties (formerly EMX Royalty Corp.) and Continental General Insurance Company, as well as certain insiders of Camino. The gross proceeds of the Financing will be applied towards corporate working capital, legal expenses, engineering studies, project development, and general administrative expenses. The Shares issued pursuant to the Financing are subject to a statutory hold period expiring on March 15, 2026, in acc
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom